ELITE PHARMACEUTICALS INC /NV/ sold ELTP

August 22, 2025 · Form 4 insider transaction

ELITE PHARMACEUTICALS INC /NV/ sold 500,000 shares of Elite Pharmaceuticals, Inc. at $0.52 per share, a transaction worth $262.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
500,000
Price
$0.52
Total value
$262.1K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 22, 2025
Filing dateAugust 26, 2025
Shares owned after1,800,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.52 to $0.56, inclusive. The reporting person undertakes to provide to Elite Phannaceuticals, any security holder of Elite Pharmaceuticals, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote(1) to this Form 4

View the original Form 4 on SEC EDGAR
ELITE PHARMACEUTICALS INC /NV/ sold ELTP: August 22, 2025 | Insider Trading Screener